Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, Poland.
NxStage Medical, Inc. (Fresenius Medical Care), Lawrence, Massachusetts, USA.
Hemodial Int. 2020 Oct;24(4):470-479. doi: 10.1111/hdi.12864. Epub 2020 Aug 11.
Definitive clinical studies to determine the optimal dialysate lactate concentration to prescribe during frequent hemodialysis when using the NxStage System One dialysis delivery system at low dialysate flow rates have not been reported.
We used clinical data from patients who transferred from in-center thrice-weekly hemodialysis (ICHD) to daily home hemodialysis using the NxStage System One and the H mobilization model to calculate acid generation rates in patient sub-groups during the FREEDOM study. Assuming those acid generation rates were representative, we then predicted using the H mobilization model the effect of using dialysate lactate concentrations of 40 and 45 mEq/L on predialysis serum total carbon dioxide (tCO ) concentrations in patients who transfer from ICHD to short and nocturnal frequent hemodialysis prescriptions used in current clinical practice; the prescriptions evaluated varied by treatment frequency, dialysate volume per treatment, and treatment times.
With frequencies of four to six treatments per week and treatment times of 170 to 210 minutes per treatment, the effect of dialysate lactate concentration was primarily dependent on weekly dialysate volume. For weekly dialysate volumes of 150 to 160 L per week, use of dialysate lactate concentrations of 45 mEq/L, but not 40 mEq/L, resulted in an increase of predialysis serum tCO concentration. When longer treatment times typical of nocturnal frequent hemodialysis were evaluated, model predictions showed that the use of dialysate lactate concentration of 45 mEq/L may not be appropriate for many patients because of excessive increases in predialysis serum tCO concentration. Reducing dialysate volume from 60 to 30 L may limit the increase in predialysis serum tCO concentration when patients transfer from ICHD to nocturnal frequent hemodialysis.
Predictions from the H mobilization model show that dialysate lactate concentration and weekly dialysate volume are the primary prescription parameters for optimizing predialysis serum tCO concentration during short and nocturnal frequent hemodialysis.
在使用 NxStage System One 透析输送系统以低透析液流速进行频繁血液透析时,尚未报道有明确的临床研究来确定在处方时使用的最佳透析液乳酸盐浓度。
我们使用了从转移到使用 NxStage System One 和 H 动员模型进行每日家庭血液透析的中心内每周三次血液透析(ICHD)的患者的临床数据,来计算 FREEDOM 研究中患者亚组的酸生成率。假设这些酸生成率具有代表性,然后我们使用 H 动员模型预测,对于转移到目前临床实践中使用的短时间和夜间频繁血液透析处方的患者,使用 40 和 45mmol/L 透析液乳酸盐浓度对透析前血清总二氧化碳(tCO )浓度的影响;评估的处方因治疗频率、每次治疗的透析液量和治疗次数而异。
每周治疗 4 至 6 次,每次治疗时间 170 至 210 分钟,透析液乳酸盐浓度的影响主要取决于每周透析液量。对于每周透析液量为 150 至 160L/周,使用 45mmol/L 的透析液乳酸盐浓度,但不是 40mmol/L,会导致透析前血清 tCO 浓度增加。当评估典型的夜间频繁血液透析的较长治疗时间时,模型预测表明,对于许多患者来说,使用 45mmol/L 的透析液乳酸盐浓度可能不合适,因为透析前血清 tCO 浓度会过度增加。当患者从 ICHD 转移到夜间频繁血液透析时,将透析液量从 60 减少到 30L 可能会限制透析前血清 tCO 浓度的增加。
H 动员模型的预测表明,透析液乳酸盐浓度和每周透析液量是优化短时间和夜间频繁血液透析期间透析前血清 tCO 浓度的主要处方参数。